Patrycja S Matusik1, Amira Bryll2, Paweł T Matusik3,4, Tadeusz J Popiela2. 1. Department of Radiology, University Hospital, Skawińska 8 Street, 33-332 Kraków, Poland. 2. Department of Diagnostic Imaging, Jagiellonian University Medical College. 3. Institute of Cardiology, Jagiellonian University Medical College, Prądnicka 80 Street, 31-202 Kraków, Poland. pawel.matusik@wp.eu. 4. Department of Electrocardiology, The John Paul II Hospital, Prądnicka 80 Street, 31-202 Kraków, Poland. pawel.matusik@wp.eu.
Abstract
BACKGROUND: Late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) may reveal myocardial fibrosis which is associated with adverse clinical outcomes in patients undergoing implantable cardioverter-defibrillator (ICD) placement. At the same time, transmural LGE in the posterolateral wall is related to nonresponse to conventional cardiac resynchronization therapy (CRT). Herein, the aim was to assess the presence and determinants of LGE in CMR in heart failure (HF) with reduced ejection fraction. METHODS: Sixty-seven patients were included (17.9% female, aged 45 [29-60] years), who underwent LGE-CMR and had left ventricular ejection fraction (LVEF) as determined by echocardiography. RESULTS: In HF patients with LVEF ≤ 35% (n = 29), ischemic and non-ischemic patterns of LGE were observed in 51.7% and 34.5% of patients, respectively. In controls (n = 38), these patterns were noted in 23.7% and 42.1% of patients, respectively. HF patients with LVEF ≤ 35% and transmural LGE in the posterolateral wall (31.0%) were characterized by older age, coronary artery disease (CAD) and previous myocardial infarction (MI) (61 ± 6 vs. 49 ± 16 years, p = 0.008, 100% vs. 40%, p = 0.003 and 78% vs. 25%, p = 0.014, respectively). In patients with LVEF ≤ 35%, LGE of any type, diagnosed in 86.2% of patients, was associated with CAD (68% vs. 0%, p = 0.02), while only trends were observed for its association with older age and previous MI (p = 0.08 and p = 0.12, respectively). CONCLUSIONS: Among HF patients with LVEF ≤ 35%, clinical factors including older age, CAD, and previous MI are associated with transmural LGE in the posterolateral wall, while CAD is associated with LGE. This data may have potential implications for planning ICD and CRT placement procedures.
BACKGROUND: Late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) may reveal myocardial fibrosis which is associated with adverse clinical outcomes in patients undergoing implantable cardioverter-defibrillator (ICD) placement. At the same time, transmural LGE in the posterolateral wall is related to nonresponse to conventional cardiac resynchronization therapy (CRT). Herein, the aim was to assess the presence and determinants of LGE in CMR in heart failure (HF) with reduced ejection fraction. METHODS: Sixty-seven patients were included (17.9% female, aged 45 [29-60] years), who underwent LGE-CMR and had left ventricular ejection fraction (LVEF) as determined by echocardiography. RESULTS: In HFpatients with LVEF ≤ 35% (n = 29), ischemic and non-ischemic patterns of LGE were observed in 51.7% and 34.5% of patients, respectively. In controls (n = 38), these patterns were noted in 23.7% and 42.1% of patients, respectively. HFpatients with LVEF ≤ 35% and transmural LGE in the posterolateral wall (31.0%) were characterized by older age, coronary artery disease (CAD) and previous myocardial infarction (MI) (61 ± 6 vs. 49 ± 16 years, p = 0.008, 100% vs. 40%, p = 0.003 and 78% vs. 25%, p = 0.014, respectively). In patients with LVEF ≤ 35%, LGE of any type, diagnosed in 86.2% of patients, was associated with CAD (68% vs. 0%, p = 0.02), while only trends were observed for its association with older age and previous MI (p = 0.08 and p = 0.12, respectively). CONCLUSIONS: Among HFpatients with LVEF ≤ 35%, clinical factors including older age, CAD, and previous MI are associated with transmural LGE in the posterolateral wall, while CAD is associated with LGE. This data may have potential implications for planning ICD and CRT placement procedures.
Entities:
Keywords:
cardiac magnetic resonance; cardiac resynchronization therapy; heart failure; implantable cardioverter-defibrillator; ischemic; late gadolinium enhancement; transmural late gadolinium enhancement
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Ravi G Assomull; Sanjay K Prasad; Jonathan Lyne; Gillian Smith; Elizabeth D Burman; Mohammed Khan; Mary N Sheppard; Philip A Poole-Wilson; Dudley J Pennell Journal: J Am Coll Cardiol Date: 2006-10-31 Impact factor: 24.094
Authors: Jens Vogel-Claussen; Carlos E Rochitte; Katherine C Wu; Ihab R Kamel; Thomas K Foo; João A C Lima; David A Bluemke Journal: Radiographics Date: 2006 May-Jun Impact factor: 5.333
Authors: Sujata M Shanbhag; Anders M Greve; Thor Aspelund; Erik B Schelbert; J Jane Cao; Ragnar Danielsen; Guðmundur Þorgeirsson; Sigurður Sigurðsson; Guðný Eiríksdóttir; Tamara B Harris; Lenore J Launer; Vilmundur Guðnason; Andrew E Arai Journal: Eur Heart J Date: 2019-02-07 Impact factor: 29.983
Authors: Sarah J Gutman; Benedict T Costello; Stavroula Papapostolou; Aleksandr Voskoboinik; Leah Iles; Johnson Ja; James L Hare; Andris Ellims; Peter M Kistler; Thomas H Marwick; Andrew J Taylor Journal: Eur Heart J Date: 2019-02-07 Impact factor: 29.983
Authors: Anca Florian; Anna Ludwig; Markus Engelen; Johannes Waltenberger; Sabine Rösch; Udo Sechtem; Ali Yilmaz Journal: J Cardiovasc Magn Reson Date: 2014-09-25 Impact factor: 5.364
Authors: Romy Roosmarijn Maria Jacqueline Josepha Hegeman; Martin John Swaans; Jan-Peter van Kuijk; Patrick Klein Journal: J Clin Med Date: 2022-08-18 Impact factor: 4.964